Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of gevokizumab in patients with acute gout.

Trial Profile

Phase II trial of gevokizumab in patients with acute gout.

Suspended
Phase of Trial: Phase II

Latest Information Update: 31 Dec 2008

At a glance

  • Drugs Gevokizumab (Primary)
  • Indications Gout
  • Focus Therapeutic Use
  • Sponsors XOMA
  • Most Recent Events

    • 31 Dec 2008 Status changed from planning to suspended
    • 06 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top